Jan 15, 2009 -- The Court of Appeals for the Federal Circuit in Washington, D.C. today found Boston Scientific Corporation's Ding patent invalid, and reversed a 2005 jury finding that Cordis Corporation's CYPHER Sirolimus-eluting Coronary Stent infringed that patent.
The details can be read here.
The whole judgement can be read here.
No comments:
Post a Comment